BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2649657)

  • 1. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
    Babany G; Morris RE; Babany I; Shepherd S; Kates RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):893-9. PubMed ID: 2649657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine.
    Babany G; Morris RE; Babany I; Kates RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):259-62. PubMed ID: 3275773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacology of FK-506.
    Morris RE; Hoyt EG; Murphy MP; Shorthouse R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1042-4. PubMed ID: 2468201
    [No Abstract]   [Full Text] [Related]  

  • 4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenobarbital and cimetidine on experimental cyclosporine nephrotoxicity: preliminary observations.
    Schwass DE; Sasaki AW; Houghton DC; Benner KE; Bennett WM
    Clin Nephrol; 1986; 25 Suppl 1():S117-20. PubMed ID: 3708921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.
    Lagodzinski Z; Górski A; Wasik M
    Immunology; 1990 Sep; 71(1):148-50. PubMed ID: 1698713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
    Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation.
    Tanaka Y; Hasegawa T; Chen Z; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):744-51. PubMed ID: 19698865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effect of cyclosporine A and SDZ RAD on neointima formation of carotid allografts in apolipoprotein E-deficient mice.
    Matsumoto Y; Hof A; Baumlin Y; Hof RP
    Transplantation; 2003 Oct; 76(8):1166-70. PubMed ID: 14578747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine and murine allergic contact dermatitis.
    Rullan PP; Barr RJ; Cole GW
    Arch Dermatol; 1984 Sep; 120(9):1179-83. PubMed ID: 6332577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of gastrointestinal agents on resorption and metabolism of cyclosporine after heart transplantation: experimental and clinical results.
    Reichenspurner H; Meiser BM; Muschiol F; Nollert G; Uberfuhr P; Markewitz A; Wagner F; Pfeiffer M; Reichart B
    J Heart Lung Transplant; 1993; 12(6 Pt 1):987-92. PubMed ID: 8312324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new rat infection-heart transplant model: effect of infection on graft survival studies.
    Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
    J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclosporin A and G with and without azathioprine regarding immunosuppressive efficacy, toxicity, and pharmacokinetics in Lewis rats.
    Hagberg RC; Hoyt EG; Billingham ME; Sibley RK; Starnes VA; Baldwin JC
    J Heart Transplant; 1988; 7(5):359-69. PubMed ID: 3058906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.